Factors/(min-maxvalues) EPCT Enrollment p-valuea
Enrolled (n=50) Non-Enrolled (n=50)
Mean SD Mean SD
TreatmentExpectationsPromoters          
Symptomsimprovement (5-25) 18.84 5.32 22.98 2.58 <0.001
Disease control (12-20) 18.92 1.95 18.82 1.78 0.789
High quality medical care (5-15) 13.80 2.05 14.20 1.26 0.243
Personal/Social Promoters          
Hopefulness (6-20) 15.22 3.84 15.50 4.17 0.727
Medical teaminfluence (7-15) 13.50 2.43 13.60 1.80 0.815
Social influences (6-15) 12.54 2.53 12.94 2.39 0.418
Barriers          
Decisionmaking (6-24) 19.52 4.16 19.82 3.20 0.687
Trial related (3-12) 7.62 2.52 8.20 2.35 0.237
Socioeconomic (8-20) 17.18 3.15 16.92 2.49 0.648
Distrust of the medical system (3-12) 7.10 2.88 8.90 2.84 0.002
Fear/uncertainty of new treatment (4-16) 11.32 3.68 12.66 3.12 0.053
Fatalistic/Spiritual beliefs (4-16) 11.36 3.06 8.66 3.21 <0.001
aTwo-sided p-value from independent t-test.
Table 3: Means Comparison of Summary Scores of Promoters and Barriers by Enrollment Status (N=100).